ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2026)
ENDRA Life Sciences (NDRA) reported Net Cash Flow of -$405903.0 for Q1 2026, up 65.15% year-over-year from -$245783.2 in Q1 2025, and down 1181.58% quarter-over-quarter from -$31672.0 in Q4 2025.
ENDRA Life Sciences (NDRA) Net Cash Flow (2016 - 2026) Analysis & Trends
ENDRA Life Sciences (NDRA) has 11 years of Net Cash Flow data on file, last reported at -$405903.0 in Q1 2026.
- Net Cash Flow for Q1 2026 came in at -$405903.0, up 65.15% year-over-year; the trailing twelve-month figure through Mar 2026 was -$1.7 million (down 283.67% YoY), and the FY2025 annual result was -$2.5 million, down 723.68% from the prior year.
- Net Cash Flow retreated to -$405903.0 in Q1 2026 per NDRA's latest filing, from -$31672.0 in the prior quarter.
- Over five years, Net Cash Flow peaked at $5.3 million in Q2 2024 and troughed at -$3.3 million in Q3 2022.
- A 5-year average of -$535592.4 and a median of -$1.2 million in 2025 frame the typical range for Net Cash Flow.
- The sharpest annual moves came in 2022 and 2024: Net Cash Flow surged 248.27% in 2022, then tumbled 202.76% in 2024.
- A 5-year view of Net Cash Flow shows it stood at -$3.1 million in 2022, then soared by 83.99% to -$500629.0 in 2023, then plunged by 202.76% to -$1.5 million in 2024, then soared by 97.91% to -$31672.0 in 2025, then tumbled by 1181.58% to -$405903.0 in 2026.
- Business Quant data shows NDRA's Net Cash Flow at -$405903.0 in Q1 2026, -$31672.0 in Q4 2025, and -$1.0 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | NCF (Qtr) |
|---|---|---|---|---|---|
| 1 | Waters | 29,902.70 Bn | 29,902.24 Bn | 1.11 Bn | -121.00 Mn |
| 2 | Thermo Fisher Scientific | 175.99 Bn | 172.74 Bn | 7.74 Bn | -6.68 Bn |
| 3 | Danaher | 129.87 Bn | 124.18 Bn | 3.59 Bn | 1.12 Bn |
| 4 | Idexx Laboratories | 44.75 Bn | 44.55 Bn | 722.74 Mn | 21.27 Mn |
| 5 | Agilent Technologies | 37.52 Bn | 35.72 Bn | 990.00 Mn | 56.00 Mn |
| 6 | Iqvia Holdings | 30.91 Bn | 28.94 Bn | 1.36 Bn | -11.00 Mn |
| 7 | Natera | 30.21 Bn | 29.11 Bn | 696.04 Mn | 11.79 Mn |
| 8 | Illumina | 24.19 Bn | 23.04 Bn | 721.00 Mn | -328.00 Mn |
| 9 | Mettler Toledo International | 23.12 Bn | 23.06 Bn | 555.82 Mn | -5.89 Mn |
| 10 | ENDRA Life Sciences | 5.25 Mn | 4.90 Mn | - | -405,903.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -405,903.00 |
| Mar 31, 2026 | -405,903.00 |
| Dec 31, 2025 | -31,672.00 |
| Dec 31, 2025 | -31,672.00 |
| Sep 30, 2025 | -1.01 Mn |
| Sep 30, 2025 | -1.01 Mn |
| Jun 30, 2025 | -256,300.00 |
| Jun 30, 2025 | -256,300.00 |
| Mar 31, 2025 | -1.16 Mn |
| Mar 31, 2025 | -1.16 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Dec 31, 2024 | -1.52 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Sep 30, 2024 | -1.66 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Jun 30, 2024 | 5.27 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Mar 31, 2024 | -1.70 Mn |
| Dec 31, 2023 | -500,629.00 |
| Dec 31, 2023 | -500,629.00 |